| The clinically active BTK inhibitor PCI-32765 targets B-cell receptor–and chemokine-controlled adhesion and migration in chronic lymphocytic leukemia MFM de Rooij, A Kuil, CR Geest, E Eldering, BY Chang, JJ Buggy, ... Blood, The Journal of the American Society of Hematology 119 (11), 2590-2594, 2012 | 660 | 2012 |
| CD20 deficiency in humans results in impaired T cell–independent antibody responses TW Kuijpers, RJ Bende, PA Baars, A Grummels, IAM Derks, KM Dolman, ... The Journal of clinical investigation 120 (1), 214-222, 2010 | 498 | 2010 |
| miR-34a as part of the resistance network in chronic lymphocytic leukemia T Zenz, J Mohr, E Eldering, AP Kater, A Bühler, D Kienle, D Winkler, ... Blood, The Journal of the American Society of Hematology 113 (16), 3801-3808, 2009 | 347 | 2009 |
| Expression profiling via novel multiplex assay allows rapid assessment of gene regulation in defined signalling pathways E Eldering, CA Spek, HL Aberson, A Grummels, IA Derks, AF de Vos, ... Nucleic acids research 31 (23), e153-e153, 2003 | 256 | 2003 |
| Histone deacetylase inhibitors suppress inflammatory activation of rheumatoid arthritis patient synovial macrophages and tissue AM Grabiec, S Krausz, W De Jager, T Burakowski, D Groot, ME Sanders, ... The journal of immunology 184 (5), 2718-2728, 2010 | 249 | 2010 |
| The Noxa/Mcl-1 axis regulates susceptibility to apoptosis under glucose limitation in dividing T cells NL Alves, IAM Derks, E Berk, R Spijker, RAW van Lier, E Eldering Immunity 24 (6), 703-716, 2006 | 234 | 2006 |
| Differential Noxa/Mcl-1 balance in peripheral versus lymph node chronic lymphocytic leukemia cells correlates with survival capacity LA Smit, DYH Hallaert, R Spijker, B de Goeij, A Jaspers, AP Kater, ... Blood 109 (4), 1660-1668, 2007 | 217 | 2007 |
| APRIL promotes B-1 cell-associated neoplasm L Planelles, CE Carvalho-Pinto, G Hardenberg, S Smaniotto, W Savino, ... Cancer cell 6 (4), 399-408, 2004 | 216 | 2004 |
| Venetoclax plus rituximab in relapsed chronic lymphocytic leukemia: 4-year results and evaluation of impact of genomic complexity and gene mutations from the MURANO phase III study AP Kater, JQ Wu, T Kipps, B Eichhorst, P Hillmen, J D’rozario, S Assouline, ... Journal of Clinical Oncology 38 (34), 4042, 2020 | 185 | 2020 |
| IL-21 and CD40L signals from autologous T cells can induce antigen-independent proliferation of CLL cells MF Pascutti, M Jak, JM Tromp, IAM Derks, EBM Remmerswaal, ... Blood, The Journal of the American Society of Hematology 122 (17), 3010-3019, 2013 | 167 | 2013 |
| The costimulatory molecule CD27 maintains clonally diverse CD8+ T cell responses of low antigen affinity to protect against viral variants KPJM van Gisbergen, PL Klarenbeek, NAM Kragten, PPA Unger, ... Immunity 35 (1), 97-108, 2011 | 162 | 2011 |
| CD27–CD70 interactions sensitise naive CD4+ T cells for IL-12-induced Th1 cell development MF Van Oosterwijk, H Juwana, R Arens, K Tesselaar, MHJ Van Oers, ... International immunology 19 (6), 713-718, 2007 | 162 | 2007 |
| Potentiation of C1 inhibitor by glycosaminoglycans: dextran sulfate species are effective inhibitors of in vitro complement activation in plasma. WA Wuillemin, H Te Velthuis, YT Lubbers, CP De Ruig, E Eldering, ... Journal of immunology (Baltimore, Md.: 1950) 159 (4), 1953-1960, 1997 | 162 | 1997 |
| c-Abl kinase inhibitors overcome CD40-mediated drug resistance in CLL: implications for therapeutic targeting of chemoresistant niches DYH Hallaert, A Jaspers, CJ van Noesel, MHJ van Oers, AP Kater, ... Blood, The Journal of the American Society of Hematology 112 (13), 5141-5149, 2008 | 157 | 2008 |
| Resistance to ABT-199 induced by microenvironmental signals in chronic lymphocytic leukemia can be counteracted by CD20 antibodies or kinase inhibitors R Thijssen, E Slinger, K Weller, CR Geest, T Beaumont, MHJ Van Oers, ... Haematologica 100 (8), e302, 2015 | 150 | 2015 |
| Chronic lymphocytic leukemia cells impair mitochondrial fitness in CD8+ T cells and impede CAR T-cell efficacy JAC van Bruggen, AWJ Martens, JA Fraietta, T Hofland, SH Tonino, ... Blood, The Journal of the American Society of Hematology 134 (1), 44-58, 2019 | 145 | 2019 |
| Enhanced formation and survival of CD4+ CD25hi Foxp3+ T-cells in chronic lymphocytic leukemia M Jak, M Jak, R Mous, EBM Remmerswaal, R Spijker, A Jaspers, ... Leukemia & lymphoma 50 (5), 788-801, 2009 | 133 | 2009 |
| Modulation of contact system proteases by glycosaminoglycans: selective enhancement of the inhibition of factor XIa WA Wuillemin, E Eldering, F Citarella, CP de Ruig, H ten Cate, CE Hack Journal of Biological Chemistry 271 (22), 12913-12918, 1996 | 129 | 1996 |
| A hinge region mutation in C1-inhibitor (Ala436–> Thr) results in nonsubstrate-like behavior and in polymerization of the molecule. KS Aulak, E Eldering, CE Hack, YP Lubbers, RA Harrison, A Mast, ... Journal of Biological Chemistry 268 (24), 18088-18094, 1993 | 126 | 1993 |
| CD40 stimulation of B‐cell chronic lymphocytic leukaemia cells enhances the anti‐apoptotic profile, but also Bid expression and cells remain susceptible to autologous cytotoxic … AP Kater, LM Evers, EBM Remmerswaal, A Jaspers, MF Oosterwijk, ... British journal of haematology 127 (4), 404-415, 2004 | 121 | 2004 |
Arnon KaterHoogleraar HematologieGeverifieerd e-mailadres voor amsterdamumc.nl
